These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 18720094)
1. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Heinonen TY; Maki M Ann Med; 2009; 41(1):2-10. PubMed ID: 18720094 [TBL] [Abstract][Full Text] [Related]
2. Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats. Hess D; Keusch JJ; Oberstein SA; Hennekam RC; Hofsteenge J J Biol Chem; 2008 Mar; 283(12):7354-60. PubMed ID: 18199743 [TBL] [Abstract][Full Text] [Related]
3. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase. Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199 [TBL] [Abstract][Full Text] [Related]
5. Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays. Berardinelli SJ; Haltiwanger RS Methods Mol Biol; 2020; 2043():25-43. PubMed ID: 31463900 [TBL] [Abstract][Full Text] [Related]
6. Peters'-Plus syndrome: report on an unusual case. Camera G; Pozzolo S; Carta M; Righi E Pathologica; 1994 Dec; 86(6):673-5. PubMed ID: 7617402 [TBL] [Abstract][Full Text] [Related]
7. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Lesnik Oberstein SA; Kriek M; White SJ; Kalf ME; Szuhai K; den Dunnen JT; Breuning MH; Hennekam RC Am J Hum Genet; 2006 Sep; 79(3):562-6. PubMed ID: 16909395 [TBL] [Abstract][Full Text] [Related]
9. Kivlin syndrome and Peters'-Plus syndrome: are they the same disorder? Thompson EM; Winter RM; Baraitser M Clin Dysmorphol; 1993 Oct; 2(4):301-16. PubMed ID: 7508317 [TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of B3GALTL in Peters Plus syndrome. Reis LM; Tyler RC; Abdul-Rahman O; Trapane P; Wallerstein R; Broome D; Hoffman J; Khan A; Paradiso C; Ron N; Bergner A; Semina EV Am J Med Genet A; 2008 Oct; 146A(20):2603-10. PubMed ID: 18798333 [TBL] [Abstract][Full Text] [Related]
11. ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome. Holdener BC; Percival CJ; Grady RC; Cameron DC; Berardinelli SJ; Zhang A; Neupane S; Takeuchi M; Jimenez-Vega JC; Uddin SMZ; Komatsu DE; Honkanen R; Dubail J; Apte SS; Sato T; Narimatsu H; McClain SA; Haltiwanger RS Hum Mol Genet; 2019 Dec; 28(24):4053-4066. PubMed ID: 31600785 [TBL] [Abstract][Full Text] [Related]
12. Severe Peters Plus syndrome-like phenotype with anterior eye staphyloma and hypoplastic left heart syndrome: proposal of a new syndrome. Shimizu R; Saito R; Hoshino K; Ogawa K; Negishi T; Nishimura J; Mitsui N; Osawa M; Ohashi H Congenit Anom (Kyoto); 2010 Sep; 50(3):197-9. PubMed ID: 20584037 [TBL] [Abstract][Full Text] [Related]
13. A novel nonsense B3GALTL mutation confirms Peters plus syndrome in a patient with multiple malformations and Peters anomaly. Aliferis K; Marsal C; Pelletier V; Doray B; Weiss MM; Tops CM; Speeg-Schatz C; Lesnik SA; Dollfus H Ophthalmic Genet; 2010 Dec; 31(4):205-8. PubMed ID: 21067481 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome. Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587 [TBL] [Abstract][Full Text] [Related]